JPMorgan Chase & Co. Forecasts Strong Price Appreciation for Lam Research (NASDAQ:LRCX) Stock

23 Apr 2026, 11:06 by Doug Wharley · The Cerbat Gem

Lam Research (NASDAQ:LRCX – Get Free Report) had its target price raised by equities research analysts at JPMorgan Chase & Co. from $300.00 to $315.00 in a report issued on Thursday,MarketScreener reports. The firm currently has an “overweight” rating on the semiconductor company’s stock. JPMorgan Chase & Co.‘s target price indicates a potential upside of 18.96% from the company’s previous close.

Several other research analysts have also weighed in on the company. Argus lifted their price objective on Lam Research from $175.00 to $280.00 in a research report on Tuesday, February 3rd. New Street Research raised their target price on Lam Research from $140.00 to $235.00 and gave the stock a “neutral” rating in a research note on Tuesday, March 31st. UBS Group set a $300.00 target price on Lam Research in a report on Thursday, January 29th. Erste Group Bank lowered Lam Research from a “buy” rating to a “hold” rating in a research note on Thursday, April 2nd. Finally, Rothschild & Co Redburn raised their price objective on shares of Lam Research from $225.00 to $265.00 and gave the stock a “buy” rating in a research report on Friday, February 6th. Twenty-seven research analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the company’s stock. According to MarketBeat.com, Lam Research has a consensus rating of “Moderate Buy” and an average price target of $272.73.

Check Out Our Latest Research Report on LRCX

Lam Research Trading Down 0.3%

Shares of LRCX stock opened at $264.79 on Thursday. Lam Research has a 1-year low of $67.55 and a 1-year high of $273.50. The company has a current ratio of 2.26, a quick ratio of 1.61 and a debt-to-equity ratio of 0.37. The stock has a market cap of $330.67 billion, a price-to-earnings ratio of 54.26, a PEG ratio of 2.75 and a beta of 1.78. The stock has a 50-day moving average of $233.80 and a 200-day moving average of $196.58.

Lam Research (NASDAQ:LRCX – Get Free Report) last posted its quarterly earnings data on Wednesday, April 22nd. The semiconductor company reported $1.47 EPS for the quarter, topping analysts’ consensus estimates of $1.36 by $0.11. Lam Research had a return on equity of 62.81% and a net margin of 30.22%.The company had revenue of $5.84 billion for the quarter, compared to analyst estimates of $5.70 billion. During the same period in the previous year, the firm earned $1.04 earnings per share. The firm’s quarterly revenue was up 23.8% on a year-over-year basis. Lam Research has set its Q4 2026 guidance at 1.500-1.800 EPS. On average, equities research analysts forecast that Lam Research will post 5.3 earnings per share for the current year.

Insider Buying and Selling

In other news, Director Eric Brandt sold 35,000 shares of the stock in a transaction that occurred on Friday, February 6th. The shares were sold at an average price of $225.60, for a total transaction of $7,896,000.00. Following the completion of the transaction, the director directly owned 253,705 shares of the company’s stock, valued at $57,235,848. This represents a 12.12% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Ava Harter sold 4,000 shares of the firm’s stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $232.50, for a total transaction of $930,000.00. Following the sale, the insider owned 54,705 shares of the company’s stock, valued at approximately $12,718,912.50. The trade was a 6.81% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders have sold 130,886 shares of company stock valued at $29,658,802. 0.31% of the stock is owned by insiders.

Institutional Trading of Lam Research

A number of large investors have recently bought and sold shares of LRCX. PMV Capital Advisers LLC bought a new position in shares of Lam Research during the 4th quarter worth $25,000. Stance Capital LLC purchased a new stake in Lam Research during the third quarter valued at about $26,000. Bayban bought a new position in Lam Research during the fourth quarter worth about $26,000. Vermillion Wealth Management Inc. bought a new position in Lam Research during the first quarter worth about $26,000. Finally, Triumph Capital Management purchased a new position in shares of Lam Research in the third quarter worth about $27,000. 84.61% of the stock is owned by hedge funds and other institutional investors.

Key Lam Research News

Here are the key news stories impacting Lam Research this week:

Positive Sentiment: Lam reported fiscal Q3 results above estimates — $1.47 non-GAAP EPS vs. $1.36 consensus and $5.84B revenue (up 23.8% YoY). The release highlights record revenue and improved margins that underpinned the rally. PR Newswire
Positive Sentiment: Management raised FYQ4 guidance: EPS $1.50–1.80 and revenue guidance midpoint (~$6.6B) came in above street expectations, signaling continued WFE strength. That upside to guidance is a primary driver of the rally. MarketBeat — Earnings
Positive Sentiment: AI-driven chip demand is cited repeatedly as the demand engine — analysts and press note expanding spending on AI logic and memory fabs is lifting orders and margins for Lam’s etch/dep tools. Globe and Mail — Deep Dive
Positive Sentiment: Wall Street raised targets and reiterated buys after the beat — examples include Needham ($300), BofA ($330) and TD Cowen ($340) — adding momentum as analysts push valuation higher. TipRanks — Ratings
Neutral Sentiment: The company’s earnings call transcript and slide deck are available for investors digging into product-level demand, backlog and capex cadence. Seeking Alpha — Call Transcript
Neutral Sentiment: Lam is named as a supplier for large-scale projects (e.g., Tesla Terafab), which supports long-duration revenue potential but requires execution and timelines to play out. Barchart — Terafab
Negative Sentiment: Some commentators warn LRCX faces an earnings “test” after a sharp pre-report rally; elevated valuation metrics (P/E >50) mean expectations are high and leave limited room for disappointment. Seeking Alpha — Caution

About Lam Research

(Get Free Report)

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.